Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

Microbio 310 > Chapter 28: Adaptive Immunity & Diagnostics (Exam 4) > Flashcards

Chapter 28: Adaptive Immunity & Diagnostics (Exam 4) Flashcards

1
Q

MHC I

A

present peptides of 8-11 amino acids
from endogenous (intracellular) foreign antigens
alerts immune system it has been infected
cell gets destroyed by T cell excreting perforins and granzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

MHC II

A

present 10-20 amino acids
from exogenous (extracellular) pathogens
after endocytosis of pathogens,
alerts immune system to antigens presence
does not kill presenting kills

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

other terms for antibody

A

immunoglobulin (IG)
B cell receptor (BCR)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

antibody production

A

B cells contain antibodies on surface (~100k per cell)
1. BCR recognizes epitope on pathogen, B cell phagocytoses antigen
2. presents antigens of enclosed pathogen on surface (MHC II) to T helper cells
3. T helpers produce cytokines that stimulate division of antigen reactive B cells –> differentiate into plasma cells
4. Secretion of large amounts of antibodies specific to the antigen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Functions of antibodies

A

mark pathogen surface
inhibit infection
neutralize toxins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Marking a pathogen’s surface

A

most common function of antibodies
phagocytes have unspecific antibody recognizing receptors, phagocytosis of IG-coated cell or virus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

inhibiting infection

A

interferes with pathogen’s outer structures
e.g. antibodies in mucous membranes hinder influenza

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

neutralizing toxins

A

binds to toxins
e.g. antibodies in blood and lymph block toxins from binding with host cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

cytotoxic T cell

A

kills cells that have the antigen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

T helper cell

A

binds MHC II
produces cytokines & interleukins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

natural active immunity

A

getting a disease and recovering

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

natural passive immunity

A

passing antibodies to infants through breast milk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

artificial passive immunity

A

receiving a vaccination and developing immunity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

artificial passive immunity

A

receiving pre-formed antibodies (antiserum)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

properties of innate immune system

A

targets common pathogens
responds within hours
non-inducible
doesnt require pre-exposure
does not generate memory
driven by phagocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

phagocytes

A

white blood cells able to ingest kill and digest pathogens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

properties of adaptive immune system

A

targets specific pathogens
responds after days
induced by innate
requires pre-exposure
generates immunity
driven by lymphocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

lymphocytes

A

white blood cells that make antibodies & mark pathogens for destruction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

immune system hypersensitivity

A

inappropriate immune response that results in host damage
two major types: antibody mediated and cell mediated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

type I hypersensitivity

A

immediate
IgE sensitization of mast cells
latency- minutes
ex. reaction to bee sting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

type II hypersensitivity

A

cytotoxic
IgG interaction with cell surface antigen
latency- hours
ex. drug reactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

type III hypersensitivty

A

immune complex
IgG interaction with soluble or circulating antigen
latency- hours
ex. systemic lupus erythematpsus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

type IV hypersensitivity

A

delayed type
Th1 inflammatory cell activation of macrophages
latency- 24-48 hrs
ex. poison ivy

24
Q

type I (immediate) allergies

A

increase or decrease bp or hr
mild or life threatening
ex. pollen, mold, shellfish, insect venom
immune system alert through mucous membranes of lungs or gut
antibody mediated

25
type IV (delayed) allergies
often after contact skin (contact dermatitis) itchiness, reddening, edema, tissue damage, blisters ex. jewelry, cosmetics, poison ivy, latex cell mediated
26
Type I diabetes
organ: pancreas mechanism: cell mediated immunity and autoantibodies against surface and cytoplasmic antigens of beta cells or pancreatic islets (II and IV) tissue/cell specific
27
Myasthenia gravis
organ: skeletal muscles mechanism: autoantibodies against acetylcholine receptors on skeletal muscle (II)
28
Goodpasture's syndrome
organ: kidney mechanism: autoantibodies against basement membrane of kidney glomeruli (II)
29
rheumatoid arthritis
organ: cartilage mechanism: autoantibodies against self IgG antibodies which form complexes deposited in joint tissue, causing inflammation and cartilage destruction (III) systemic
30
systemic lupus erythematosus
affects: DNA, cardiolipin, nucleoprotein, blood clotting proteins mechanism: autoantibody response to various cellular constituents results in immune complex formation (III)
31
multiple sclerosis
unknown cause body's immune system attacks its own tissues, destroys fatty substance that coats and protects nerve fibers in the brain and spinal cord (myelin)
32
superantigens
proteins capable of elicitng a strong response because they activate more t cells than a normal immune response produced by many viruses and bacteria that interact with t cell receptors may produce systemic diseases characterized by systemic inflammatory reactions some influenza, toxic shock, graft vs host, cytokine storm covid, immunotherapies
33
immunodeficiency
active adaptive immunity is critical for infectious disease resistance animals with deficiencies in B cells are prone to bacterial infections t cell deficiencies prone to viral infections and cancers
34
severe combined immune deficiency syndrom (SCID)
serious, congenital deficiency in both B and T cells patients live a restricted life to limit exposure to pathogens adenine deaminase X-SCID interlukin receptor missing, expresses on T, B and NK cells omenn syndrome rag gene mutations (recombination activating gene)
35
acquired immunodeficiency syndrome (AIDS)
caused by HIV infection that progresses and kills CD4 & T cells patients are prone to opportunistic infections and cancer since deficienct in T cell help
36
Avastin
immunotherapy anti VEGF antibody tumors produce protein VEGF which binds to receptors on blood vessels which helps it grow and spread Avastin attaches to VEGF, preventing it from binding to receptors, existing blood vessels may shrink away from tumor, prevents new vessels from forming
37
herceptin anti her2 ab
immunotherapy normal: her2 receptors send signals telling cells to grow and divide breast cancer: too many her2 receptors send signals too quickly, causing rapid cell growth herceptin: stops her2 from signaling growth
38
immunotherapy
type of cancer treatment designed to boost body's natural defenses to fight cancer uses substances either made by body or in lab to improve or restore immune function
39
opdivo keytruda anti PDL abs
immunotherapy -PD-1 expressed on antigen stimulated T cells & induces downstream signaling that inhibits T cell proliferation, cytokine release & cytotoxicity -many tumors (melanoma) suppress cytotoxic T cell activity by expressing PD-1 ligand on cell surface -anti-PD-1 and PD-L1 antibodies can reverse T-cell suppression and induce long lasting antitumor responses
40
CAR T-cell therapy
Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells
41
two forms of relapse after CAR-T cell infusions
antigen-positive relapse antigen escape
42
antigen-positive relapse
occurs in early phase closely related to car-t cell persistance
43
antigen escape/loss
occurs in later phases alternative splicing primary cause, gradually develop into dominant clusters under strong immune pressure
44
trogocytosis
Trogocytosis occurs when one cell contacts and quickly nibbles another cell and is characterized by contact between living cells and rapid transfer of membrane fragments with functional integrity. Many immune cells are involved in this process, such as T cells, B cells, NK cells, APCs
45
cytokine release syndrome
a condition that may occur after treatment with some types of immunotherapy, such as monoclonal antibodies and CAR-T cells caused by large, rapid release of cytokines into blood from immune cells affected by the immunotherapy
46
immunotherapy and the gut microbiome
composition of each persons gut microbiota plays significant role in efficacy of given treatments goal is to determine as precisely as possibly which microbes confer beneficial effect and formulating a probiotic suspension of just those organisms
47
historical spontaneous regressions of cancer
rhodenburg: 185 cases in 1918 fauvet: 202 cases 1960-1964 boyd: 98 cases 1966 everson & cole: 176 1900-1960 challis: 489 1900-1987 hobohm: meta analysis of 1000 cases, frequency estimated to be 1 in 100,000 cancers
48
why study malignant melanoma in tumor immunology
visible model for melanoma regression occurs with auto-immunity to melanocyte self-antigens (vitiligio) specific t-cell and humoral responses occur vitiligo patterns may be template of antigen repertoire immune system can recognize any tumor
49
immonoassays and disease
serological reactions used for many diagnostic immunology tests and often use monoclonal antibodies (MBAS) clinical diagnostic tests that use MBAS include typing of bacterial pathogens, identification of cells containing foreign surface antigens and highly specific blood and tissue typing, detect and treat cancer
50
monoclonal antibodies
produced by isolating single clones of B cells that are fused with cancer cells to make immortalized cell lines that produce a single type of antibody
51
direct agglutination
results when soluble antibody causes clumping due to interaction with an antigen that is an integral part of the surface of a cell or other insoluble particle used for classification of antigens found on surface of RBCs
52
passive agglutination
the agglutination of soluble antigens or antibodies that have been absorbed or chemically coupled to cells or insoluble particles reactions can be up to 5x more sensitive than direct agglutination
53
enzyme immonoassay (EIA) or enzyme linked immunosorbent assay (ELISA)
very sensitive immunological assay widely used in clinical diagnostic & research EIAS employ covalently bonded enzymes attached to antibody molecules rapid tests similar to EIAS both allow detection of antigen-antibody complexes
54
rapid tests
similar to EIAS but results can be recorded in minutes not hours provide point of care diagnostics not as specific or sensitive reagents absorbed to support material body fluid applied to support matrix matrix contains soluble antigen conjugated to colored molecule (chromophore) & line of fixed antigen which antibodies bind to, detect color change ex. pregnancy, strep, hiv, covid, rsv tests
55
immunoblot / western blot
electrophoresis of proteins, followed by transfer to a membrane & detection by addition of specific antibodies immunoblot methods detect antibodies to specific antigens or antigens themselves ex. hiv antibodies, confirmatory test for hiv rapid test

Microbio 310 (6 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions